These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15644697)

  • 1. Agitation in the critically ill patient: a marker of health or a plea for treatment?
    Schweickert W; Hall JB
    Crit Care Med; 2005 Jan; 33(1):263-5. PubMed ID: 15644697
    [No Abstract]   [Full Text] [Related]  

  • 2. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients.
    Milbrandt EB; Kersten A; Kong L; Weissfeld LA; Clermont G; Fink MP; Angus DC
    Crit Care Med; 2005 Jan; 33(1):226-9; discussion 263-5. PubMed ID: 15644675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistemology of delirium in the critically ill: preemptive or therapeutic approach?
    Corona A; Colombo R; Raimondi F
    Crit Care Med; 2011 May; 39(5):1241-2; author reply 1242-3. PubMed ID: 21610604
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of haloperidol in the agitated, critically ill pediatric patient with burns.
    Brown RL; Henke A; Greenhalgh DG; Warden GD
    J Burn Care Rehabil; 1996; 17(1):34-8. PubMed ID: 8808357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.
    Duprey MS; Devlin JW; van der Hoeven JG; Pickkers P; Briesacher BA; Saczynski JS; Griffith JL; van den Boogaard M
    Crit Care Med; 2021 Aug; 49(8):1303-1311. PubMed ID: 33861548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedation and pain management in critically ill adults.
    Arbour R
    Crit Care Nurse; 2000 Oct; 20(5):39-56; quiz 57-8. PubMed ID: 11878487
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of haloperidol in agitated critically ill children.
    Harrison AM; Lugo RA; Lee WE; Appachi E; Bourdakos D; Davis SJ; McHugh MJ; Weise KL
    Clin Pediatr (Phila); 2002; 41(1):51-4. PubMed ID: 11866368
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
    Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
    Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
    van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
    Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients.
    Yeo QM; Wiley TL; Smith MN; Hammond DA
    Crit Care Nurs Q; 2017; 40(4):344-362. PubMed ID: 28834857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awake or Sedated: Trends in the Evaluation and Management of Agitation in the Intensive Care Unit.
    DeBiasi EM; Akgün KM; Pisani M
    Semin Respir Crit Care Med; 2015 Dec; 36(6):899-913. PubMed ID: 26595050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
    Isenberg DL; Jacobs D
    Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling agitated delirium--the tip of the iceberg.
    Page VJ
    Crit Care; 2009; 13(3):158. PubMed ID: 19591644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological modelling of agitation-sedation dynamics.
    Rudge AD; Chase JG; Shaw GM; Lee D
    Med Eng Phys; 2006 Jan; 28(1):49-59. PubMed ID: 15869894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sedation in the critically ill patient.
    Durbin CG
    New Horiz; 1994 Feb; 2(1):64-74. PubMed ID: 7922431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2008-2018: Ten years of gradual changes in the sedation guidelines for critically ill patients.
    Chanques G; Drouot X; Payen JF
    Anaesth Crit Care Pain Med; 2018 Dec; 37(6):509-511. PubMed ID: 30580774
    [No Abstract]   [Full Text] [Related]  

  • 17. Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis.
    Crowley KE; Urben L; Hacobian G; Geiger KL
    Clin Ther; 2020 Apr; 42(4):e65-e73. PubMed ID: 32273047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of haloperidol infusions to control delirium in critically ill adults.
    Seneff MG; Mathews RA
    Ann Pharmacother; 1995; 29(7-8):690-3. PubMed ID: 8520081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events of haloperidol for the treatment of delirium in critically ill children.
    Slooff VD; Spaans E; van Puijenbroek E; Jessurun N; van Beusekom BS; de Hoog M; Tibboel D; de Wildt SN
    Intensive Care Med; 2014 Oct; 40(10):1602-3. PubMed ID: 25183567
    [No Abstract]   [Full Text] [Related]  

  • 20. Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial.
    Carrasco G; Baeza N; Cabré L; Portillo E; Gimeno G; Manzanedo D; Calizaya M
    Crit Care Med; 2016 Jul; 44(7):1295-306. PubMed ID: 26925523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.